Scaling omics approaches to population size
See talks from the Scaling omics approaches to population size biobank symposium, 11th-12th November 2020
Human biological material combined with clinical and demographic registries are the most critical resources for translating the researchbased advances in molecular biology and advanced technologies into improved human health.
Human diversity as dictated by variation in the sequences of genomes can now be characterized in depth at the population scale. Coupled with longitudinal information about disease risk factors, causal processes and outcomes, an unparalleled opportunity currently exists to optimize prevention, diagnosis and treatment of many acute and chronic diseases.
Based on these prerequisites and world-class research communities, several Nordic biobanks have taken giant steps from merely being biorepositories to becoming excellent research communities for genetic epidemiology and translational medicine.
With this biobank symposium, we will bring together world-leading biobanks, researchers and experts in ethical, legal and societal implications to discuss how we can leverage the full potential of omics and achieve population-scale sample sizes. The technical side is important but so is the donor and political perspective.
The symposium is kindly sponsored by the Novo Nordisk Foundation.
Talks will also be made available as audio podcasts at PodBean.